Kostmann syndrome and severe congenital neutropenia

Seminars in Hematology

Volumn 39, Issue 2, 2002, Pages 82-88

  Zeidler, Cornelia ^a   Welte, Karl ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

LEUKOCYTE ELASTASE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

AUTOSOMAL RECESSIVE INHERITANCE; CHRONIC DISEASE; DISEASE SEVERITY; DRUG EFFECT; GENE MUTATION; HEMATOLOGIC DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; KOSTMANN SYNDROME; LEUKEMIA; MALIGNANT TRANSFORMATION; MYELOPOIESIS; NEUTROPENIA; OSTEOPOROSIS; POINT MUTATION; PRIORITY JOURNAL; QUALITY OF LIFE; RECEPTOR GENE; REVIEW; SPLENOMEGALY; VASCULITIS;

EID: 0036216657     PISSN: 00371963     EISSN: None     Source Type: Journal    
DOI: 10.1053/shem.2002.31913     Document Type: Article

References (29)

1. Paternal mosaicism proves the pathogenic nature of mutations in neutrophil elastase in severe congenital neutropenia
2. Effects of recombinant human granulocyte colony-stimulating factor on neutropenia in patients with congenital agranulocytosis
3. Long-term safety of treatment with recombinant human granulocyte colonystimulating factor (r-metHuG-CSF) in patients with severe congenital neutropenias
4. Mutations of the granulocyte-colony stimulating factor receptor in patients with severe congenital neutropenia are not required for transformation to acute myeloid leukaemia and may be a bystander phenomenon
5. Diagnosis and clinical course of autoimmune neutropenia in infancy: Analysis of 240 cases
6. A randomized controlled phase III trial of recombinant human granulocyte colonystimulating factor (Filgrastim) for treatment of severe chronic neutropenia
7. Mutations in the gene encoding neutrophil elastase in congenital and cyclic neutropenia
8. Mutations in the gene for the granulocyte-colony stimulating factor receptor in patients with acute myeloid leukemia preceded by severe congenital neutropenia
9. Safety of long-term administration of granulocyte colony-stimulating factor for severe chronic neutropenia
10. Mutations in the gene encoding neutrophil elastase (ELA2) are not sufficient to cause the phenotype of congenital neutropenia
11. Congenital agranulocytosis: Prolonged survival and terminal acute leukemia
12. Mutations in ELA2, encoding neutrophil elastase, define a 21-day biological clock in cyclic haematopoesis
13. Infantile genetic agranulocytosis
14. Infantile genetic agranulocytosis: A review with presentation of ten new cases
15. Expression of receptors for granulocyte-colony stimulating factor on neutrophils from patients with severe congenital neutropenia and cyclic neutropenia
16. Increased serum levels of granulocyte colony-stimulating factor in patients with severe congenital neutropenia
17. Molecular cloning and expression of cDNA for human granulocyte colony-stimulating factor
18. Correction of infantile granulocytosis (Kostmann syndrome) by allogeneic bone marrow transplantation
19. Congenital agranulocytosis terminating in acute myelomonocytic leukemia
20. Recombinant human granulocyte colony-stimulating factor: Effects on normal and leukemic myeloid cells
21. Clinical relevance of point mutations in the cytoplasmatic domain of the granulocyte-colony stimulating factor gene in patients with severe congenital neutropenia
22. Time course of increasing numbers of mutations in the granulocyte colony-stimulating factor receptor gene in a patient with congenital neutropenia who developed leukemia
23. High incidence of significant bone loss in patients with severe congenital neutropenia (Kostmann's syndrome)
24. Differential effects of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor in children with severe congenital neutropenia
25. Pathophysiology and treatment of severe chronic neutropenia
26. Severe chronic neutropenia: Pathophysiology and therapy
27. Beneficial effects of stem cell factor (SCF) in children with severe congenital neutropenias refractory to G-CSF
28. Stem cell transplantation in patients with severe congenital neutropenia without evidence of leukemic transformation
29. Management of Kostmann syndrome in the G-CSF era